Abbott Labs: Steadily Getting Back To Normal

11:10am, Monday, 20'th Mar 2023
Abbott has had a crazy couple of years, with a formula recall and a COVID testing boom. Through this year, most of that should start to normalize, and the Libre 3 launch and growth in the diabetes mar

What Is Driving Growth For Abbott Stock?

08:00am, Monday, 20'th Mar 2023
After a 10% fall year-to-date, at the current levels, Abbott stock (NYSE: ABT) has room for growth, in our view.
In this article, we dive into Abbott Laboratories, one of the few dividend kings with a dividend growth track record of at least 50 consecutive annual hikes. The company comes with a decent dividend y
Prior to February 28, 2023, readers mentioned 38 equities in recent comments on Arnold articles. Some bad-news investments (rogues) mixed with (mostly) favorites. Thus, these are ReFa/Ro. Ten analyst-
Abbott (ABT) currently forecasts total organic sales growth, excluding the impact of COVID testing-related sales, to be in the high-single digits in 2023.
While it is not the only factor to consider, the annual dividend can solidify whether a stock will benefit you financially. And among the many industry sectors to invest in, healthcare can be one of t

DivHut Portfolio Update: February 2023

05:38am, Tuesday, 14'th Mar 2023
The system is clearly broken and has been for a while; however, I could find comfort in one thing, my dividends. These days, there are no shortages of accidental high yielding stocks but look at real
Abbott Laboratories (ABT) receives FDA clearance for the integration of its iCGM system sensors with automated insulin delivery (AID) systems.
PepsiCo and Abbott Laboratories both possess tremendous brand power. The two companies should continue to reward shareholders with rising dividends.

My 12 Best Dividend Kings For March 2023

02:14pm, Wednesday, 08'th Mar 2023
The 49 Dividend Kings started the new year on a positive note but cooled off in February, collectively losing 2.06%. The 11 best dividend kings selected for February, based on forecasted growth and va
Abbott's (ABT) Alinity i TBI lab test provides a new reliable result in 18 minutes to support clinicians in quickly assessing concussion and triaging patients.
Abbott Laboratories (ABT) demonstrates the superiority of the TriClip device in treating patients with severe, symptomatic tricuspid regurgitation.

3 Value Stocks on Sale Now

04:33pm, Tuesday, 07'th Mar 2023
Growth stocks have clearly led the market thus far in 2023, but will that continue?
Results from Abbott's (ABT) PORTICO study support Navitor's recent FDA approval to treat patients with severe aortic stenosis who are at high or extreme risk for open-heart surgery.
Abbott's (ABT) landmark COAPT trial demonstrated that MitraClip is safe and effective and can reduce the hospitalization rate.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE